标题
Hepatitis C therapy in non-genotype 1 patients: the near future
作者
关键词
-
出版物
JOURNAL OF VIRAL HEPATITIS
Volume 19, Issue 8, Pages 525-536
出版商
Wiley
发表日期
2012-07-05
DOI
10.1111/j.1365-2893.2012.01634.x
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- 1 ATOMIC: 97% RVR FOR PSI-7977 + PEG/RBV × 12 WEEK REGIMEN IN HCV GT1: AN END TO RESPONSE-GUIDED THERAPY?
- (2012) K.V. Kowdlev et al. JOURNAL OF HEPATOLOGY
- 1213 EFFICACY AND SAFETY OF MERICITABINE (MCB) IN COMBINATION WITH PEG-IFNa-2A/RBV IN G1/4 TREATMENT NAIVE HCV PATIENTS: FINAL ANALYSIS FROM THE PROPEL STUDY
- (2012) H. Wedemeyer et al. JOURNAL OF HEPATOLOGY
- 1405 ALISPORIVIR PLUS RIBAVIRIN IS HIGHLY EFFECTIVE AS INTERFERON-FREE OR INTERFERON-ADD-ON REGIMEN IN PREVIOUSLY UNTREATED HCV-GT2 OR GT3 PATIENTS: SVR12 RESULTS FROM VITAL-1 PHASE 2B STUDY
- (2012) J.-M. Pawlotsky et al. JOURNAL OF HEPATOLOGY
- 1422 POTENT VIRAL SUPPRESSION WITH ALL-ORAL COMBINATION OF DACLATASVIR (NS5A INHIBITOR) AND GS-7977 (NS5B INHIBITOR), +/− RIBAVIRIN, IN TREATMENT-NAIVE PATIENTS WITH CHRONIC HCV GT1, 2, OR 3
- (2012) M. Sulkowski et al. JOURNAL OF HEPATOLOGY
- 1205 SVR-12 AMONG G1/4 TREATMENT-NAIVE PATIENTS RECEIVING MERICITABINE IN COMBINATION WITH PEG-IFNa-2A/RBV: INTERIM ANALYSIS FROM THE JUMP-C STUDY
- (2012) P. Pockros et al. JOURNAL OF HEPATOLOGY
- 1177 RAPID AND SUSTAINED ACHIEVEMENT OF UNDETECTABLE HCV RNA DURING TREATMENT WITH RITONAVIR-BOOSTED DANOPREVIR/PEG-IFNa-2A/RBV IN HCV GENOTYPE 1 OR 4 PATIENTS: DAUPHINE WEEK 12 INTERIM ANALYSIS
- (2012) G. Everson et al. JOURNAL OF HEPATOLOGY
- Antiviral activity of TMC435 monotherapy in patients infected with HCV genotypes 2–6: TMC435-C202, a phase IIa, open-label study
- (2012) Christophe Moreno et al. JOURNAL OF HEPATOLOGY
- 10 PEGINTERFERON LAMBDA-1A (LAMBDA) COMPARED TO PEGINTERFERON ALFA-2A (ALFA) IN TREATMENT-NAIVE PATIENTS WITH HCV GENOTYPES (G) 2 OR 3: FIRST SVR24 RESULTS FROM EMERGE PHASE IIB
- (2012) S. Zeuzem et al. JOURNAL OF HEPATOLOGY
- 1113 ELECTRON: ONCE DAILY PSI-7977 PLUS RBV IN HCV GT1/2/3
- (2012) E.J. Gane et al. JOURNAL OF HEPATOLOGY
- Treatment Results of Chronic Hepatitis C Genotype 5 and 6 Infections in Germany
- (2012) S. Mauss et al. ZEITSCHRIFT FUR GASTROENTEROLOGIE
- Hepatitis C Therapy: Other Players in the Game
- (2011) Joseph Ahn et al. Clinics in Liver Disease
- The NS5A Replication Complex Inhibitors: Difference Makers?
- (2011) Robert G. Gish et al. Clinics in Liver Disease
- The HCV NS5B Nucleoside and Non-Nucleoside Inhibitors
- (2011) Fernando E. Membreno et al. Clinics in Liver Disease
- Telaprevir Alone or With Peginterferon and Ribavirin Reduces HCV RNA in Patients With Chronic Genotype 2 but Not Genotype 3 Infections
- (2011) Graham R. Foster et al. GASTROENTEROLOGY
- Differential Efficacy of Protease Inhibitors Against HCV Genotypes 2a, 3a, 5a, and 6a NS3/4A Protease Recombinant Viruses
- (2011) Judith M. Gottwein et al. GASTROENTEROLOGY
- Response-guided peg-interferon plus ribavirin treatment duration in chronic hepatitis C: Meta-analyses of randomized, controlled trials and implications for the future
- (2011) Vincent Di Martino et al. HEPATOLOGY
- IL28Bgenetic variation and treatment response in patients with hepatitis C virus genotype 3 infection
- (2011) Amir Moghaddam et al. HEPATOLOGY
- 1360 PEGYLATED INTERFERON-LAMBDA (PEGIFN-λ) SHOWS SUPERIOR VIRAL RESPONSE WITH IMPROVED SAFETY AND TOLERABILITY VERSUS PEGIFNα-2A IN HCV PATIENTS (Gl/2/3/4): EMERGE PHASE IIB THROUGH WEEK 12
- (2011) S. Zeuzem et al. JOURNAL OF HEPATOLOGY
- 61 ONCE DAILY PSI-7977 PLUS PEGIFN/RBV IN A PHASE 2B TRIAL: RAPID VIROLOGIC SUPPRESSION IN TREATMENT-NAIVE PATIENTS WITH HCV GT2/GT3
- (2011) J. Lalezari et al. JOURNAL OF HEPATOLOGY
- EASL Clinical Practice Guidelines: Management of hepatitis C virus infection
- (2011) JOURNAL OF HEPATOLOGY
- IL28B polymorphism is associated with treatment response in patients with genotype 4 chronic hepatitis C
- (2011) Tarik Asselah et al. JOURNAL OF HEPATOLOGY
- Response-guided therapy for patients with hepatitis C virus genotype 6 infection: a pilot study
- (2011) P. Tangkijvanich et al. JOURNAL OF VIRAL HEPATITIS
- Boceprevir for Untreated Chronic HCV Genotype 1 Infection
- (2011) Fred Poordad et al. NEW ENGLAND JOURNAL OF MEDICINE
- Response-Guided Telaprevir Combination Treatment for Hepatitis C Virus Infection
- (2011) Kenneth E. Sherman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Boceprevir for Previously Treated Chronic HCV Genotype 1 Infection
- (2011) Bruce R. Bacon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Telaprevir for Retreatment of HCV Infection
- (2011) Stefan Zeuzem et al. NEW ENGLAND JOURNAL OF MEDICINE
- Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection
- (2011) Ira M. Jacobson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Vitamin D supplementation improves sustained virologic response in chronic hepatitis C (genotype 1)-naïve patients
- (2011) Saif Abu-Mouch WORLD JOURNAL OF GASTROENTEROLOGY
- Impact of IL28B Genotype on the Early and Sustained Virologic Response in Treatment-Naïve Patients With Chronic Hepatitis C
- (2010) Albert Friedrich Stättermayer et al. Clinical Gastroenterology and Hepatology
- An IL28B Polymorphism Determines Treatment Response of Hepatitis C Virus Genotype 2 or 3 Patients Who Do Not Achieve a Rapid Virologic Response
- (2010) Alessandra Mangia et al. GASTROENTEROLOGY
- Replicated Association Between an IL28B Gene Variant and a Sustained Response to Pegylated Interferon and Ribavirin
- (2010) Jeanette J. McCarthy et al. GASTROENTEROLOGY
- Genetic Variation in IL28B Is Associated With Chronic Hepatitis C and Treatment Failure: A Genome-Wide Association Study
- (2010) Andri Rauch et al. GASTROENTEROLOGY
- Sustained virological response with 29 days of Debio 025 monotherapy in hepatitis C virus genotype 3
- (2010) H. Patel et al. GUT
- 37 SUSTAINED VIROLOGIC RESPONSE (SVR) FOLLOWING RG7128 1500MG BID/PEG-IFN/RBV FOR 28 DAYS IN HCV GENOTYPE 2/3 PRIOR NON-RESPONDERS
- (2010) E.J. Gane et al. JOURNAL OF HEPATOLOGY
- Importance of IL28B gene polymorphisms in hepatitis C virus genotype 2 and 3 infected patients
- (2010) Christoph Sarrazin et al. JOURNAL OF HEPATOLOGY
- Management of hepatitis C virus genotype 4: Recommendations of An International Expert Panel
- (2010) Mahmoud A. Khattab et al. JOURNAL OF HEPATOLOGY
- Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect
- (2010) Min Gao et al. NATURE
- In Vitro Activity and Preclinical Profile of TMC435350, a Potent Hepatitis C Virus Protease Inhibitor
- (2009) T.-I Lin et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- The cyclophilin inhibitor Debio 025 combined with PEG IFNα2a significantly reduces viral load in treatment-naïve hepatitis C patients
- (2009) Robert Flisiak et al. HEPATOLOGY
- Silibinin Is a Potent Antiviral Agent in Patients With Chronic Hepatitis C Not Responding to Pegylated Interferon/Ribavirin Therapy
- (2008) Peter Ferenci et al. GASTROENTEROLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now